Northern Trust
BIAF icon

Northern Trust’s bioAffinity Technologies BIAF Stock Holding History

Northern Trust’s Portfolio BIAF Stock Details BIAF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$13.6K Buy
16,748
+4,023
+32% +$8.22K ﹤0.01% 4397
2026
Q1 		$48.7K Hold
12,725
– – ﹤0.01% 4249
2025
Q4 		$15K Buy
+12,725
New +$25.3K ﹤0.01% 4413
2025
Q3 		– Sell
-455
Closed -$3.92K – 4438
2025
Q2 		$3.92K Hold
455
– – ﹤0.01% 4395
2025
Q1 		$3.55K Hold
455
– – ﹤0.01% 4412
2024
Q4 		$12.4K Hold
455
– – ﹤0.01% 4413
2024
Q3 		$28.4K Hold
455
– – ﹤0.01% 4296
2024
Q2 		$29.5K Hold
455
– – ﹤0.01% 4290
2024
Q1 		$27.6K Buy
+455
New +$23.7K ﹤0.01% 4302

Other funds holding BIAF

JSSH
J. Safra Sarasin Holding $6.97B AUM 32.91% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
AF
Allworth Financial Folsom, California $23.6B AUM 20.99% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Northern Trust's BIAF Position: Q2 2026 in Review

Northern Trust increased its bioAffinity Technologies (BIAF) stake by 32% in Q2 2026, buying an estimated $8.22K and bringing the position to 16,748 shares worth $13.6K. The position accounts for ﹤0.01% of the portfolio, ranked #4397.

Northern Trust first reported a position in BIAF in Q1 2024 and has held it in 9 quarters since. The position peaked at $48.7K in Q1 2026. 14 funds tracked by Wall St. Rank hold BIAF as of Q2 2026.

  • Northern Trust held 16,748 shares of bioAffinity Technologies worth $13.6K as of Q2 2026.
  • Northern Trust bought 4,023 bioAffinity Technologies shares in Q2 2026, an estimated $8.22K.
  • bioAffinity Technologies made up ﹤0.01% of Northern Trust's portfolio in Q2 2026, its #4397 holding.
  • Northern Trust first reported a position in bioAffinity Technologies in Q1 2024 and has held it in 9 quarters since.
  • Northern Trust's bioAffinity Technologies position peaked at $48.7K in Q1 2026.
  • 14 funds tracked by Wall St. Rank held bioAffinity Technologies as of Q2 2026.

Based on Northern Trust's 13F filing for Q2 2026, filed 13 Aug 2026.